{
    "2019-03-29": [
        [
            {
                "time": "2018-03-01",
                "original_text": "Can These Biotech Stocks Take On Arthritis Powerhouse AbbVie?",
                "features": {
                    "keywords": [
                        "biotech stocks",
                        "arthritis",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-02",
                "original_text": "Wall Street is buzzing about Gilead’s rheumatoid arthritis drug. Here’s why",
                "features": {
                    "keywords": [
                        "Gilead",
                        "rheumatoid arthritis",
                        "drug"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-01",
                "original_text": "Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates",
                "features": {
                    "keywords": [
                        "biotech investors",
                        "PDUFA dates"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-02",
                "original_text": "Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug Approvals",
                "features": {
                    "keywords": [
                        "AZN",
                        "ABBV",
                        "NVS",
                        "drug approvals"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-03",
                "original_text": "Gilead & Galapagos Announce Positive Data on Arthritis Drug",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Galapagos",
                        "arthritis drug",
                        "positive data"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-03",
                "original_text": "Analysts Raise Neurocrine Biosciences’ Target Price in March",
                "features": {
                    "keywords": [
                        "Neurocrine Biosciences",
                        "target price"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}